Company Filing History:
Years Active: 2009
Title: Graham Warrellow: Innovator in Selective COX-2 Inhibitors
Introduction
Graham Warrellow is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of selective COX-2 inhibitors. His work is characterized by a focus on innovative chemical compounds that have potential medical applications.
Latest Patents
Warrellow holds a patent for "2-phenylpyran-4-one derivatives as selective COX-2 inhibitors." This invention relates to 2-phenylpyran-4-derivatives of general formula (I), processes for their preparation, pharmaceutical compositions containing them, and their medical uses. This patent highlights his commitment to advancing therapeutic options in the medical field.
Career Highlights
Graham Warrellow is currently associated with Laboratorios Almirall, S.A., a company known for its focus on innovative pharmaceutical solutions. His role at the company allows him to leverage his expertise in chemistry and pharmacology to develop new treatments that can improve patient outcomes.
Collaborations
One of his notable collaborators is Juan Francisco Caturla Javaloyes. Their partnership exemplifies the collaborative spirit in the field of pharmaceutical research, where teamwork often leads to groundbreaking discoveries.
Conclusion
Graham Warrellow's contributions to the field of selective COX-2 inhibitors demonstrate his innovative spirit and dedication to improving healthcare. His work continues to inspire advancements in pharmaceutical research and development.